ACI FDA Approval ANDA 215772

ANDA 215772

ACI

FDA Drug Application

Application #215772

Application Sponsors

ANDA 215772ACI

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 250MG BASE0AZITHROMYCINAZITHROMYCIN

FDA Submissions

UNKNOWN; ORIG1AP2022-07-15STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

ACI
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215772
            [companyName] => ACI
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 250MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/15\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-07-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.